BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

897 related articles for article (PubMed ID: 16496232)

  • 21. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.
    Taghavi SA; Eshraghian A; Niknam R; Sivandzadeh GR; Bagheri Lankarani K
    Expert Rev Gastroenterol Hepatol; 2018 Jun; 12(6):575-584. PubMed ID: 29781738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary sclerosing cholangitis patients with serial polysomy fluorescence in situ hybridization results are at increased risk of cholangiocarcinoma.
    Barr Fritcher EG; Kipp BR; Voss JS; Clayton AC; Lindor KD; Halling KC; Gores GJ
    Am J Gastroenterol; 2011 Nov; 106(11):2023-8. PubMed ID: 21844920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM; Vleggaar FP; Tytgat KM; Siersema PD; van Buuren HR
    J Hepatol; 2009 Jan; 50(1):158-64. PubMed ID: 19012991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA; Shackleton CR; Farmer DG; Arnaout WS; Seu P; Markowitz JS; Martin P; Stribling RJ; Goldstein LI; Busuttil RW
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of cholangiocarcinoma with magnetic resonance spectroscopy of bile in patients with and without primary sclerosing cholangitis.
    Albiin N; Smith IC; Arnelo U; Lindberg B; Bergquist A; Dolenko B; Bryksina N; Bezabeh T
    Acta Radiol; 2008 Oct; 49(8):855-62. PubMed ID: 18608012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience.
    Kaya M; de Groen PC; Angulo P; Nagorney DM; Gunderson LL; Gores GJ; Haddock MG; Lindor KD
    Am J Gastroenterol; 2001 Apr; 96(4):1164-9. PubMed ID: 11316165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
    Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
    Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Detection of Cholangiocarcinoma in Primary Sclerosing Cholangitis Patients: Single Center Experience.
    Kuzu UB; Ödemiş B; Suna N; Yıldız H; Parlak E; Dişibeyaz S; Torun S; Akpınar MY; Coşkun O; Turhan N; Yüksel M; Kayaçetin E
    J Gastrointest Cancer; 2016 Mar; 47(1):8-14. PubMed ID: 26537791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recall processes for biliary cytology in primary sclerosing cholangitis.
    Eaton JE; Gossard AA; Talwalkar JA
    Curr Opin Gastroenterol; 2014 May; 30(3):287-94. PubMed ID: 24686433
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnosis of cholangiocarcinoma in patients with PSC: a sight on cytology.
    Baskin-Bey ES; Moreno Luna LE; Gores GJ
    J Hepatol; 2006 Oct; 45(4):476-9. PubMed ID: 16901574
    [No Abstract]   [Full Text] [Related]  

  • 32. Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis.
    Trilianos P; Selaru F; Li Z; Gurakar A
    Digestion; 2014; 89(2):165-73. PubMed ID: 24577150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transplantation for hilar cholangiocarcinoma.
    Heimbach JK; Haddock MG; Alberts SR; Nyberg SL; Ishitani MB; Rosen CB; Gores GJ
    Liver Transpl; 2004 Oct; 10(10 Suppl 2):S65-8. PubMed ID: 15382214
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma Surveillance Recommendations in Patients with Primary Sclerosing Cholangitis.
    Saca D; Flamm SL
    Clin Liver Dis; 2024 Feb; 28(1):183-192. PubMed ID: 37945159
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
    Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
    Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical implications of serial versus isolated biliary fluorescence in situ hybridization (FISH) polysomy in primary sclerosing cholangitis.
    Quinn KP; Tabibian JH; Lindor KD
    Scand J Gastroenterol; 2017 Apr; 52(4):377-381. PubMed ID: 27908204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary sclerosing cholangitis.
    Rodriguez HJ; Bass NM
    Semin Gastrointest Dis; 2003 Oct; 14(4):189-98. PubMed ID: 14719769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advanced cholangiocarcinoma in a patient with stage I primary sclerosing cholangitis.
    Ueda M; Nakamura T; Tohyama T; Kushihata F; Honda Y; Kobayashi N
    J Hepatobiliary Pancreat Surg; 2003; 10(3):245-9. PubMed ID: 14605983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sclerosing cholangitis.
    MacFaul GR; Chapman RW
    Curr Opin Gastroenterol; 2006 May; 22(3):288-93. PubMed ID: 16550044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.